Biogen first-quarter profit rises 20 percent on Spinraza strength
April 24, 2019 at 06:51 AM EDT
Drugmaker Biogen Inc reported a 20 percent rise in first-quarter profit on Wednesday, driven by higher sales of its muscle disease treatment Spinraza.